Vivos Therapeutics (NASDAQ:VVOS) Downgraded by Zacks Investment Research

Vivos Therapeutics (NASDAQ:VVOS – Get Rating) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued on Saturday, Zacks.com reports. According to Zacks, “Vivos Therapeutics Inc. is a medical technology company. It engages in the development and commercialization of technology solutions for patients with sleep disordered […]

Related Keywords

Colorado ,United States ,Boston ,Massachusetts ,Cambridge ,Cambridgeshire ,United Kingdom ,Highlands Ranch , ,Vivos Therapeutics Inc ,Geode Capital Management ,Russell Investments Group Ltd ,Cambridge Investment Research Advisors Inc ,Zacks Investment Research ,National Asset Management Inc ,Vivos Therapeutics ,Get Rating ,Capital Management ,Investment Research Advisors ,Asset Management ,Russell Investments Group ,Investments Group ,Vivos System ,Nasdaq Vvos ,Vvos ,Medical ,Downgrade ,